Latex C-serum from Hevea brasiliensis induces non-apoptotic cell death in hepatocellular carcinoma cell line (HepG2)

Cell Proliferation

Volumn 45, Issue 6, 2012, Pages 577-585

  Lam, K L ^a   Yang, K L ^b   Sunderasan, E ^c   Ong, M T ^a  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^b SCHOOL OF PHYSICS   (Malaysia)

^c RUBBER RESEARCH INSTITUTE OF MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; LATEX; TETRAZOLIUM;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CYTOTOXICITY; DNA FRAGMENTATION; HEATING; HEVEA BRASILIENSIS; HUMAN; HUMAN CELL; LC 50; LIVER CELL CARCINOMA; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL DEATH; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEVEA; HUMANS; LATEX; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

HEVEA BRASILIENSIS;

EID: 84868211746     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2012.00841.x     Document Type: Article

References (27)

1. Kekwick R (2001) Latex and Laticifers. Encyclopedia of Life Sciences. Nature Publishing Group, 1-6.
2. Agrawal A, Konno K (2009) Latex: a model for understanding mechanisms, ecology, and evolution of plant defense against herbivory. Annu. Rev. Ecol. Evol. Syst. 40, 311-331.
3. Bealing FJ (1981) Quebrachitol synthesis in Hevea brasiliensis. J. Rubb. Res. Inst. Malaysia 29, 111-112.
4. Burton GW, Webb A, Ingold KU (1985) A mild, rapid and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids 20, 29-39.
5. Chow CK, Draper HH (1970) Isolation of gamma-tocotrienol dimers from Hevea latex. Biochemistry 9, 445-450.
6. Das G, Alam B, Raj S, Dey SK, Sethuraj MR, Senmandi S (2002) Over-exploitation associated changes in free radicals and its scavengers in Hevea brasiliensis. J. Rubb. Res. 5, 28-40.
7. Wajant H, Forster S (1996) Purification and characterization of hydroxynitrile lyase from Hevea brasiliensis. Plant Sci. 115, 25-31.
8. Archer BL, Audley BG, McSweeney GP, Tan CH (1969) Studies on composition of latex serum and 'bottom fraction' particles. J. Rubb. Res. Inst. Malaya 21, 560-569.
9. Yeang HY, Siti Arija MA, Faridah Y, Sunderasan E (2002) Allergenic proteins of natural rubber latex. Methods 27, 32-45.
10. Daruliza KMA, Yang KL, Lam KL, Priscilla JT, Sunderasan E, Ong MT (2011) Anti-Candida albicans activity and brine shrimp lethality test of Hevea brasiliensis latex B-serum. Eur. Rev. Med. Pharmacol. Sci. 15, 1163-1171.
11. Daruliza KMA, Lam KL, Yang KL, Priscilla JT, Sunderasan E, Ong MT (2011) Anti-fungal effect of Hevea brasiliensis latex C-serum on Aspergillus niger. Eur. Rev. Med. Pharmacol. Sci. 15, 1027-1033.
12. Ong MT, Yang KL, Lam KL, Ong GA, Sunderasan E (2009) Susceptibility of HeLa (cancer-origin) cells to a sub-fraction of latex B serum. J. Rubb. Res. 12, 117-124.
13. Moir GFJ (1959) Ultracentrifugation and staining of Hevea latex. Nature 184, 1626.
14. Hsia RCH (1958) Oxygen absorption by Hevea brasiliensis latex. Trans. Instn. Rubb. Ind. 34, 267-290.
15. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
16. Finney DJ (1962) Probit Analysis. Cambridge: University Press.
17. -ΔΔCT method. Methods 25, 402-408.
18. Suffness M, Pezzuto JM (1990) Assays related to cancer drug discovery. In: Hostettmenn K, ed.Methods in Plant Biochemistry: Assays for Bioactivity, Vol. 6, pp. 71-133. London: Academic Press.
19. Mothana RA, Lindequist U, Gruenert R, Bednarski PJ (2009) Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra. BMC Complement. Altern. Med. 9, 7.
20. Bosch FX, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5, Suppl. 1) S5-S16.
21. Shao W, Sui C, Liu Z, Yang J, Zhou Y (2011) Surgical outcome of hepatocellular carcinoma patients with biliary tumor thrombi. World J. Surg. Oncol. 9, 2.
22. Westerink WM, Schoonen WG (2007) Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. In Vitro 21, 1581-1591.
23. Abas HH (2001) Adverse effects of herbs and drug-herbal interactions. Malays. J. Pharm. 1, 39-44.
24. McFadyen MCE, Melvin WT, Murray GI (2004) Cytochrome P450 enzymes: novel options for cancer. Mol. Cancer Ther. 3, 363-371.
25. Rodriguez-Antona C, Ingelman-Sundberg M (2006) Cytochrome P450 pharmacogenetics and cancer. Oncogene 25, 1679-1691.
26. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cromin WM et al. (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 97, 1652-1662.
27. Cronin-Fenton DP, Lash TL (2011) Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes. Expert Rev. Clin. Pharmacol. 4, 363-377.